Back

The effect of CD38 inhibition in age-associated vascular dysfunction

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Novel insights into ageing and senescence Vascular Tone, Permeability, Microcirculation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yustina Maria Puspitasari

University of Zurich, Schlieren (Switzerland)

8 More presentations in this session

Presentation thumbnail
The BET protein inhibitor apabetalone (RVX-208) prevents doxorubicin-induced endothelial senescence
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
The role of cellular senescence in aortic dissection
Doctor E. Nakao (Kurume, JP)
Abstract Slides Video
Presentation thumbnail
Non-cell-autonomous effects of arginase-II in macrophages on cardiomyocytes in aging
Doctor D. Potenza (Fribourg, CH)
Abstract Slides Video
Presentation thumbnail
Sirt5 as a mediator of endothelial and vascular dysfunction: potential therapeutic target in aging-related vascular diseases
Doctor K. Yang (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Digoxin reduces senescence and restores dysfunctional endothelial-subcutaneous adipocyte cross-talk and dysregulated glucose homeostasis in patients with type 2 diabetes mellitus
Doctor O. Brown (Leeds, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Novel insights into ageing and senescence

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
The role of CD38 in age-related vascular dysfunction: a sex-dependent factor
thumbnail
Congress Presentation
Sirt5 as a mediator of endothelial and vascular dysfunction: potential therapeutic target in aging-related vascular diseases
thumbnail
Congress Presentation
Sirt5 in mediating endothelial and vascular dysfunction: a novel target in aging-related vascular diseases

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources